|
Re: BET inhibitors and Pulmonary Hypertension
|
4
|
Resverlogix Corp.
|
Aug 01, 2018 02:33PM
|
|
Angiochem receives $7.5 million in Series C financing
|
1
|
BIOASIS TECHNOLOGIES INC
|
Aug 02, 2018 09:17AM
|
|
Re: Things are happening
|
2
|
Resverlogix Corp.
|
Aug 02, 2018 10:33AM
|
|
Re: Will we hold our big gain today?
|
3
|
Zenith Epigenetics
|
Aug 02, 2018 10:37AM
|
|
Re: Things are happening
|
|
Resverlogix Corp.
|
Aug 02, 2018 10:43AM
|
|
Re: That was one sweet day of trading....
|
|
Resverlogix Corp.
|
Aug 02, 2018 12:46PM
|
|
Re: That was one sweet day of trading....
|
|
Resverlogix Corp.
|
Aug 02, 2018 12:53PM
|
|
Updated Van Leeuwenhoeck Institute Analyst Report and August Fact Sheet
|
8
|
Resverlogix Corp.
|
Aug 02, 2018 05:06PM
|
|
Re: Nice open on both share price and volume on the “pinks” this morning.
|
9
|
Resverlogix Corp.
|
Aug 03, 2018 11:41AM
|
|
Re: Angiochem receives $7.5 million in Series C financing
|
2
|
BIOASIS TECHNOLOGIES INC
|
Aug 03, 2018 12:50PM
|
|
Re: Nice open on both share price and volume on the “pinks” this morning.
|
9
|
Resverlogix Corp.
|
Aug 03, 2018 01:18PM
|
|
Re: Pretty quiet on the Zenith front,
|
2
|
Zenith Epigenetics
|
Aug 03, 2018 03:56PM
|
|
Re: Quiet when our Northern Neighbors take the day off
|
5
|
Resverlogix Corp.
|
Aug 06, 2018 12:47PM
|
|
Resverlogix Announces Seventh Positive Recommendation From The Data Safety Monitoring Board For Phase 3 Study of Apabetalone
|
3
|
Resverlogix Corp.
|
Aug 07, 2018 07:12AM
|
|
Re: Resverlogix Announces Seventh Positive Recommendation From The Data Safety Monitoring Board For Phase 3 Study of Apabetalone
|
4
|
Resverlogix Corp.
|
Aug 07, 2018 07:21AM
|
|
Re: New shares issued?
|
4
|
Zenith Epigenetics
|
Aug 07, 2018 11:01AM
|
|
Re: Resverlogix Announces Seventh Positive Recommendation From The Data Safety Monitoring Board For Phase 3 Study of Apabetalone
|
8
|
Resverlogix Corp.
|
Aug 07, 2018 12:04PM
|
|
Re: Is something bigger than a US listing being worked on?
|
4
|
Resverlogix Corp.
|
Aug 07, 2018 01:30PM
|
|
Re: DSMB and SSRA
|
6
|
Resverlogix Corp.
|
Aug 07, 2018 02:27PM
|
|
Special Report on Drug Delivery: Penetrating the Impenetrable
|
2
|
BIOASIS TECHNOLOGIES INC
|
Aug 07, 2018 10:07PM
|
